Show simple item record

Treating HBV/HCV Co-infected Patients with Direct Acting HCV Antivirals Only is not Safe.

dc.contributor.authorParlak, Mehmet
dc.contributor.authorÖZARAS, Reşat
dc.contributor.authorBodur, Hurrem
dc.contributor.authorLeblebicioglu, Hakan
dc.contributor.authorSunbul, Mustafa
dc.date.accessioned2021-03-02T20:33:10Z
dc.date.available2021-03-02T20:33:10Z
dc.identifier.citationÖZARAS R., Sunbul M., Parlak M., Bodur H., Leblebicioglu H., "Treating HBV/HCV Co-infected Patients with Direct Acting HCV Antivirals Only is not Safe.", HEPATOLOGY, cilt.1, ss.1, 2016
dc.identifier.issn0270-9139
dc.identifier.othervv_1032021
dc.identifier.otherav_028e1531-1612-4287-83c4-05bc1f6e641c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/7660
dc.language.isoeng
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.titleTreating HBV/HCV Co-infected Patients with Direct Acting HCV Antivirals Only is not Safe.
dc.typeMakale
dc.relation.journalHEPATOLOGY
dc.contributor.departmentOndokuz Mayıs Üniversitesi , ,
dc.identifier.volume1
dc.identifier.startpage1
dc.identifier.endpage1
dc.contributor.firstauthorID657171


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record